PUBLISHER: Grand View Research | PRODUCT CODE: 1842018
PUBLISHER: Grand View Research | PRODUCT CODE: 1842018
The Middle East pharmaceutical excipient market size was estimated at USD 278.93 million in 2024 and is projected to reach USD 354.71 million by 2033, growing at a CAGR of 2.69% from 2025 to 2033. The increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders has led to a higher demand for effective formulations that rely on advanced excipients. Rising health awareness and greater access to medical treatments are increasing prescription volumes across the region. Excipients are gaining importance as they enhance solubility, bioavailability, and stability of drugs in challenging formulations. With more patients requiring long-term therapies, controlled release and patient-friendly dosage forms are seeing higher demand. This trend is creating opportunities for excipients that improve drug delivery and compliance. As the need for innovative medicines grows, excipients are emerging as essential components in regional drug development.
Another factor driving the growth of the market is the rapid advancement of pharmaceutical technologies and formulation science. Co-processed excipients are being adopted to simplify production processes, reduce variability, and improve product performance. The shift towards complex biologics and sensitive drug molecules has accelerated the need for specialized excipients with enhanced compatibility. Nanotechnology-based excipients are enabling precise targeting and efficient delivery of active ingredients. Oral solid dosage forms remain dominant in the region, and the innovation of excipients tailored for tablets and capsules is fueling consistent demand.
For instance, in November 2023, Roquette introduced three new excipients, Lycatab CT-LM, Microcel 103 SD, and Microcel 113 SD, during the October CPHI Barcelona trade show. Lycatab CT-LM, a pre-gelatinized starch, was highlighted as a multifunctional excipient functioning as a filler, binder, and disintegrant, with an extremely low water activity (Aw) of no more than 0.1%, making it suitable for dry granulation, hard capsule filling, and direct compression processes.
Middle East Pharmaceutical Excipient Market Report Segmentation
This report forecasts revenue at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Middle East pharmaceutical excipient market report based on product, formulation, function, and country: